Advertisement

Loading...

MeiraGTx Holdings plc

MGTX•NASDAQ
Healthcare
Biotechnology
$8.66
$0.57(7.05%)
U.S. Market opens in 0h 54m

MeiraGTx Holdings plc (MGTX) Stock Overview

Explore MeiraGTx Holdings plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap697.1M
P/E Ratio-6.24
EPS (TTM)$-1.42
ROE44.39%
Fundamental Analysis

AI Price Forecasts

1 Month$6.84
3 Months$5.54
1 Year Target$10.53

MGTX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of MeiraGTx Holdings plc (MGTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 67.52, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $10.53.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.24 and a market capitalization of 697.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
7.05%
5-Day Change
13.35%
1-Month Change
14.55%
3-Month Change
8.93%
6-Month Change
5.22%
Year-to-Date (YTD) Change
10.88%
1-Year Change
27.73%
3-Year Change
67.50%
5-Year Change
-39.99%
All-Time (Max) Change
-42.27%

Contact Information

https://www.meiragtx.com
646 860 7985
430 East 29th Street, New York City, NY, 10016

Company Facts

3,750 Employees
IPO DateJun 8, 2018
CountryUS
Actively Trading

Frequently Asked Questions